Salehinejad et al., 2020 - Google Patents
An overview on mesenchymal stem cells derived from extraembryonic tissues: supplement sources and isolation methodsSalehinejad et al., 2020
View PDF- Document ID
- 3042350474948844945
- Author
- Salehinejad P
- Moshrefi M
- Eslaminejad T
- Publication year
- Publication venue
- Stem Cells and Cloning: Advances and Applications
External Links
Snippet
Purpose The main aim of this review was to provide an updated comprehensive report regarding isolation methods of MSCs from human extra embryonic tissues, including cord blood, amniotic fluid, and different parts of the placenta and umbilical cord, with respect to …
- 210000002901 Mesenchymal Stem Cells 0 title abstract description 63
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Salehinejad et al. | An overview on mesenchymal stem cells derived from extraembryonic tissues: supplement sources and isolation methods | |
Kulus et al. | Mesenchymal stem/stromal cells derived from human and animal perinatal tissues—origins, characteristics, signaling pathways, and clinical trials | |
Can et al. | Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells | |
Salehinejad et al. | Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly | |
Chatzistamatiou et al. | Optimizing isolation culture and freezing methods to preserve W harton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the H ellenic C ord B lood B ank | |
Malek et al. | Human placental stem cells: biomedical potential and clinical relevance | |
US7547546B2 (en) | Progenitor cells from wharton's jelly of human umbilical cord | |
US8900863B2 (en) | Methods for isolating mononuclear cells that include a subpopulation of mesenchymal progenitor cells and vascular cells that include a subpopulation of endothelial progenitor cells from umbilical cord tissue | |
Semenov et al. | Mesenchymal stem cells derived from Wharton’s jelly and their potential for cardio-vascular tissue engineering | |
Paladino et al. | Comparison between isolation protocols highlights intrinsic variability of human umbilical cord mesenchymal cells | |
Murphy et al. | Isolation, cryopreservation and culture of human amnion epithelial cells for clinical applications | |
US20180008649A1 (en) | Adherent stromal cells derived from placentas of multiple donors and uses thereof | |
Sreekumar et al. | G Sharma T (2014) Isolation and Characterization of Buffalo Wharton’s Jelly Derived Mesenchymal Stem Cells | |
Iacono et al. | Ultrastructural characteristics and immune profile of equine MSCs from fetal adnexa | |
Maslova et al. | Umbilical cord tissue‐derived cells as therapeutic agents | |
Zheng et al. | A robust and highly efficient approach for isolation of mesenchymal stem cells from Wharton’s jelly for tissue repair | |
Gao et al. | Clonal isolation of endothelial colony-forming cells from early gestation chorionic villi of human placenta for fetal tissue regeneration | |
US20170224736A1 (en) | Method and apparatus for recovery of umbilical cord tissue derived regenerative cells and uses thereof | |
Ghasemzadeh et al. | Comparable osteogenic capacity of mesenchymal stem or stromal cells derived from human amnion membrane and bone marrow | |
Hoseini et al. | Efficient isolation of mesenchymal stem cells from amniotic fluid via a two-step culture method | |
Emnett et al. | Evaluation of tissue homogenization to support the generation of GMP‐compliant mesenchymal stromal cells from the umbilical cord | |
Kitala et al. | The isolation and production of the ready-to-use product (the amniotic stem cell culture) in accordance with good manufacturing practice regulations | |
Teofili et al. | Incorporating placental tissue in cord blood banking for stem cell transplantation | |
Nazari-Shafti et al. | High yield recovery of equine mesenchymal stem cells from umbilical cord matrix/Wharton’s jelly using a semi-automated process | |
Meierhenry et al. | Placenta as a source of stem cells for regenerative medicine |